CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
CNY 27.6
(-0.11%)
CNY 27.6
(-0.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.47 Billion CNY | -5.85% |
| 2022 | 2.62 Billion CNY | 83.42% |
| 2021 | 1.43 Billion CNY | 8.7% |
| 2020 | 1.31 Billion CNY | 4.85% |
| 2019 | 1.25 Billion CNY | 1.32% |
| 2018 | 1.24 Billion CNY | 20.26% |
| 2017 | 1.03 Billion CNY | 15.8% |
| 2016 | 890.47 Million CNY | 20.01% |
| 2015 | 742.01 Million CNY | 14.03% |
| 2014 | 650.71 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 507.06 Million CNY | 15.3% |
| 2024 Q1 | 524.06 Million CNY | -11.68% |
| 2024 Q2 | 439.77 Million CNY | -16.08% |
| 2023 Q1 | 684.02 Million CNY | -36.51% |
| 2023 Q2 | 625.59 Million CNY | -8.54% |
| 2023 Q4 | 593.34 Million CNY | 0.18% |
| 2023 FY | 2.47 Billion CNY | -5.85% |
| 2023 Q3 | 592.26 Million CNY | -5.33% |
| 2022 Q3 | 509.64 Million CNY | -13.94% |
| 2022 FY | 2.62 Billion CNY | 83.42% |
| 2022 Q4 | 1.07 Billion CNY | 111.41% |
| 2022 Q2 | 592.18 Million CNY | 32.41% |
| 2022 Q1 | 447.22 Million CNY | 16.66% |
| 2021 Q2 | 350.29 Million CNY | -1.92% |
| 2021 FY | 1.43 Billion CNY | 8.7% |
| 2021 Q3 | 341.18 Million CNY | -2.6% |
| 2021 Q4 | 383.36 Million CNY | 12.36% |
| 2021 Q1 | 357.13 Million CNY | 25.52% |
| 2020 FY | 1.31 Billion CNY | 4.85% |
| 2020 Q4 | 284.51 Million CNY | -17.69% |
| 2020 Q3 | 345.66 Million CNY | 4.23% |
| 2020 Q1 | 355.6 Million CNY | 20.0% |
| 2020 Q2 | 331.62 Million CNY | -6.75% |
| 2019 Q3 | 306.63 Million CNY | -1.52% |
| 2019 Q2 | 311.37 Million CNY | -8.99% |
| 2019 FY | 1.25 Billion CNY | 1.32% |
| 2019 Q4 | 296.34 Million CNY | -3.35% |
| 2019 Q1 | 342.14 Million CNY | 1.1% |
| 2018 Q1 | 301.38 Million CNY | 21.89% |
| 2018 FY | 1.24 Billion CNY | 20.26% |
| 2018 Q4 | 338.42 Million CNY | 18.77% |
| 2018 Q3 | 284.93 Million CNY | -9.64% |
| 2018 Q2 | 315.34 Million CNY | 4.63% |
| 2017 Q4 | 247.25 Million CNY | 0.0% |
| 2017 Q2 | 268.33 Million CNY | 0.0% |
| 2017 Q3 | 247.25 Million CNY | -7.85% |
| 2017 FY | 1.03 Billion CNY | 15.8% |
| 2017 Q1 | 268.33 Million CNY | 0.0% |
| 2016 FY | 890.47 Million CNY | 20.01% |
| 2015 FY | 742.01 Million CNY | 14.03% |
| 2014 FY | 650.71 Million CNY | 0.0% |